Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rui Qian Yeu
Institutions:
Greenlane Clinical Centre,
Auckland District Health Board,
Health New Zealand
Observed institutions:
University of Auckland,
Auckland City Hospital,
Greenlane Clinical Centre,
Auckland District Health Board,
Maurice Wilkins Centre,
Health New Zealand
show all 6
ORCID:
0000-0003-4227-1688
Observed ORCID:
0000-0003-4227-1688
OpenAlex ID:
A5089192350
Stratified glucose-lowering response to vildagliptin and pioglitazone by obesity and hypertriglyceridemia in a randomized crossover trial
2023
·
Rebecca Brandon
, Yannan Jiang
, et al.
·
Frontiers in Endocrinology
·
5
PDF
Randomised cross-over trial of vildagliptin and pioglitazone as add-on therapy in patients with type 2 diabetes: predicting Which One is Right Here (WORTH) study protocol
2020
·
Rui Qian Yeu
, Rebecca Brandon
, et al.
·
BMJ Open
·
4
PDF
Reduced Weight Gain with Pioglitazone vs Vildagliptin in CREBRF rs373863828 A-allele Carriers: Insights from the WORTH Trial
2025
·
Zanetta Toomata
, Yannan Jiang
, et al.
·
Diabetes Metabolic Syndrome and Obesity
·
1
PDF
Community deaths from diabetic ketoacidosis: A 14‐year retrospective study in Auckland, New Zealand
2025
·
Rui Qian Yeu
, Paul L. Morrow
, et al.
·
Diabetic Medicine
PDF
Show more works
View as search
Works count:
4
Citation count:
10
H-index:
2
I10-index:
Year
Topic
Type
